MedTrace Logo

The Effects of Diet and Exercise Interventions in Peripheral Artery Disease

NCT03845036 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2026-04-17

No results posted yet for this study

Summary

This study is a 3-month, prospective, randomized controlled clinical trial designed to address the efficacy of the DASH dietary program combined with a home-based exercise program, quantified by a step activity monitor, to improve exercise and vascular outcome measures in patients with PAD.

Conditions

Interventions

BEHAVIORAL

DASH Diet plus Home-Based Exercise

The DASH dietary program consists of a diet emphasizing foods rich in fruits, vegetables, whole grains, and low-fat dairy, in which patients record daily servings of fruits and vegetables. The home-based exercise program consists of intermittent walking to moderate claudication pain 3 times per week for 3 months in a home-based setting.

BEHAVIORAL

Home-Based Exercise

The home-based exercise program consists of intermittent walking to moderate claudication pain 3 times per week for 3 months in a home-based setting.

Sponsors & Collaborators

  • Milton S. Hershey Medical Center

    collaborator OTHER

  • National Institute on Aging (NIA)

    collaborator NIH

  • Case Western Reserve University

    collaborator OTHER

  • University of Oklahoma

    lead OTHER

Principal Investigators

  • Andrew Gardner, Ph.D. · Professor, Department of Medicine, Cardiology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-16
Primary Completion
2029-05-31
Completion
2029-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03845036 on ClinicalTrials.gov